DK0636024T3 - Potensering af antimikrobielle virkninger - Google Patents

Potensering af antimikrobielle virkninger

Info

Publication number
DK0636024T3
DK0636024T3 DK93909105T DK93909105T DK0636024T3 DK 0636024 T3 DK0636024 T3 DK 0636024T3 DK 93909105 T DK93909105 T DK 93909105T DK 93909105 T DK93909105 T DK 93909105T DK 0636024 T3 DK0636024 T3 DK 0636024T3
Authority
DK
Denmark
Prior art keywords
pct
composition
preparation
monoglyceride
sec
Prior art date
Application number
DK93909105T
Other languages
English (en)
Inventor
Karin Ilund
Tz Lena-Karin L
Richard Bryland
Ake Lindahl
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Application granted granted Critical
Publication of DK0636024T3 publication Critical patent/DK0636024T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DK93909105T 1992-04-14 1993-03-31 Potensering af antimikrobielle virkninger DK0636024T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201187A SE500777C2 (sv) 1992-04-14 1992-04-14 Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
PCT/SE1993/000275 WO1993020812A1 (en) 1992-04-14 1993-03-31 Potentiation of antimicrobial effects

Publications (1)

Publication Number Publication Date
DK0636024T3 true DK0636024T3 (da) 1999-11-22

Family

ID=20385960

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93909105T DK0636024T3 (da) 1992-04-14 1993-03-31 Potensering af antimikrobielle virkninger

Country Status (15)

Country Link
US (1) US5550145A (da)
EP (1) EP0636024B1 (da)
JP (1) JP4014114B2 (da)
AT (1) ATE181502T1 (da)
AU (1) AU677580B2 (da)
CA (1) CA2118114C (da)
DE (1) DE69325450T2 (da)
DK (1) DK0636024T3 (da)
ES (1) ES2132230T3 (da)
GR (1) GR3030999T3 (da)
HK (1) HK1007923A1 (da)
NZ (1) NZ251783A (da)
SE (1) SE500777C2 (da)
SG (1) SG52341A1 (da)
WO (1) WO1993020812A1 (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411899A1 (de) * 1994-04-07 1995-10-12 Beiersdorf Ag Gegen Fußgeruch wirksame Zubereitungen mit einem Gehalt an Monoglycerinestern von Fettsäuren
ES2180636T3 (es) * 1994-05-20 2003-02-16 Novavax Inc Emulsiones antimicrobianas de aceite en agua.
US5460802A (en) * 1994-07-18 1995-10-24 Minnesota Mining And Manufacturing Company Oral disinfectant for companion animals
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
DE4434775A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäureglyceriden gegen Superinfektionen
DE4435290A1 (de) * 1994-10-01 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäuren und Fettsäureglyceriden gegen Superinfektionen
DE4436537A1 (de) * 1994-10-13 1996-04-18 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäuren und Fettsäureglyceriden gegen Superinfektionen
DE4438588A1 (de) * 1994-10-28 1996-05-02 Beiersdorf Ag Gegen unreine Haut, leichte Formen der Akne sowie Propionibacterium acnes wirksame Wirkstoffkombinationen auf der Basis von Wollwachssäuren und Glycerinestern gesättigter Fettsäuren
DE4444237C2 (de) * 1994-12-13 2000-08-24 Beiersdorf Ag Verwendung von Wirkstoffkombinationen zur Bekämpfung durch Propionibacterium acnes hervorgerufener unreiner Haut sowie leichter Formen der Akne
DE19540465A1 (de) * 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
US5700842A (en) * 1995-11-01 1997-12-23 Kimberly-Clark Worldwide, Inc. Methods of incorporating a hydrophobic substance into an aqueous solution
DE19541967A1 (de) * 1995-11-10 1997-05-15 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame Zusammensetzungen auf der Basis von Partialglyceriden und Arylverbindungen
ATE201585T1 (de) 1998-02-12 2001-06-15 Oreal Verwendung von 1,2-pentandiol in einer kosmetischen oder dermatologischen zusammensetzung, welche filmbildende polymerpartikel in wässriger dispersion enthält und kosmetische oder dermatologische zusammensetzung, enthaltend obige bestandteile
WO1999046987A1 (en) 1998-03-19 1999-09-23 Bifodan A/S Disinfecting composition
AU781957B2 (en) * 1998-06-23 2005-06-23 University Of Maryland Use of oils having a high lauric acid content as an animal feed
US6096332A (en) * 1998-06-30 2000-08-01 Mcneil-Ppc, Inc. Adding pharmaceutically active compounds to substrates
IT1317735B1 (it) * 2000-01-26 2003-07-15 Nicox Sa Sali di agenti antimicrobici.
US6429231B1 (en) * 2001-09-24 2002-08-06 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US7074832B2 (en) 2001-09-24 2006-07-11 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
SE0103528D0 (sv) * 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
DE10205190B4 (de) * 2002-02-08 2017-06-08 Beiersdorf Ag 2-Methyl-1,3-propandiol haltige Zubereitungen
US20050036972A1 (en) * 2003-03-10 2005-02-17 Hy-Gene Biomedical Corporation System for managing pathogens and irritants and monitoring usage of anti-bacterial formulations
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
JP4091566B2 (ja) * 2003-06-03 2008-05-28 株式会社マンダム 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品
SE0301862D0 (sv) * 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
US7214391B2 (en) * 2003-06-30 2007-05-08 Usana Health Sciences, Inc. Botanical extract compositions and process for preparing same
MY140194A (en) * 2003-07-16 2009-11-30 Leo Pharma As Novel fusidic acid derivatives
EP1672989B1 (en) * 2003-09-09 2012-04-25 3M Innovative Properties Company Concentrated antimicrobial compositions and methods
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
KR20060095756A (ko) * 2003-09-09 2006-09-01 쓰리엠 이노베이티브 프로퍼티즈 컴파니 항균 조성물 및 방법
US20050215634A1 (en) * 2003-11-11 2005-09-29 Schlievert Patrick M Regulation of cell membrane-mediated effects
FR2869802B1 (fr) * 2004-05-04 2010-08-20 I N E A S L Composition cosmetique et/ou dermatologique possedant des proprietes conservatrices hypoalergeniques
US8796332B2 (en) * 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
AU2005332655A1 (en) * 2004-10-20 2006-12-14 Iogenetics, Llc Biocides
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
WO2006099325A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
WO2006099359A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
KR20070113281A (ko) 2005-03-10 2007-11-28 쓰리엠 이노베이티브 프로퍼티즈 컴파니 항미생물성 조성물 및 방법
US20060204558A1 (en) * 2005-03-10 2006-09-14 Kantner Steven S Antimicrobial pet wipes and methods
RU2008135444A (ru) * 2006-02-02 2010-03-10 Лео Фарма А/С (Dk) Композиция для местного применения, содержащая антибактериальные вещества
US20080075793A1 (en) * 2006-09-21 2008-03-27 Dunshee Wayne K Antiviral compositions and methods of use
US20100105750A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
FR2954124B1 (fr) * 2009-12-18 2012-04-06 Fabre Pierre Dermo Cosmetique Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee
US20130165880A1 (en) 2010-09-17 2013-06-27 David T. Amos Antimicrobial disposable absorbent articles
US20140051650A1 (en) * 2011-04-29 2014-02-20 Effik S.A. Vaginal compositions based on alkyl polyglucosides
GB201118198D0 (en) 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to organic compounds
GB201118193D0 (en) 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to oranic compounds
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
BR112018075998A2 (pt) * 2016-06-13 2019-04-02 Vyome Therapeutics Limited. composições antifúngicas sinérgicas e métodos das mesmas

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK116528A (da) * 1966-09-30
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
JPS5814758B2 (ja) * 1977-08-23 1983-03-22 株式会社日立製作所 多層配線基板
JPS58111669A (ja) * 1981-12-25 1983-07-02 Takeda Chem Ind Ltd 食品用防腐剤および食品の防腐方法
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
CA1331559C (en) * 1986-04-21 1994-08-23 Jon Joseph Kabara Antimicrobial preservative compositions and methods
NZ221168A (en) * 1986-08-15 1989-08-29 Colgate Palmolive Co Antiseptic composition containing ethyl alcohol and monolaurin
US4997851A (en) * 1987-12-31 1991-03-05 Isaacs Charles E Antiviral and antibacterial activity of fatty acids and monoglycerides
US4847088A (en) * 1988-04-28 1989-07-11 Dow Corning Corporation Synergistic antimicrobial composition
EP0462964B1 (en) * 1989-03-13 1998-07-22 Cellegy Pharmaceuticals, Inc. Topical compositions containing aliphatic amines for the treatment of skin diseases
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
DK0593459T3 (da) * 1990-04-18 1997-07-21 Procter & Gamble Sammensætninger til behandling mod lus
FI912955A (fi) * 1990-06-25 1991-12-26 Res Found Mental Hygiene Antimikroba fettsyrasammansaettningar.
NZ250714A (en) * 1990-10-30 1996-05-28 Mcneil Ppc Inc Liquid composition comprising esters of higher fatty acids for use as a vaginal douche and to prevent toxic shock toxin production

Also Published As

Publication number Publication date
CA2118114A1 (en) 1993-10-28
SE9201187L (sv) 1993-10-15
ES2132230T3 (es) 1999-08-16
AU677580B2 (en) 1997-05-01
SE9201187D0 (sv) 1992-04-14
SG52341A1 (en) 1998-09-28
NZ251783A (en) 1996-07-26
SE500777C2 (sv) 1994-08-29
WO1993020812A1 (en) 1993-10-28
DE69325450D1 (de) 1999-07-29
GR3030999T3 (en) 1999-12-31
JPH07505880A (ja) 1995-06-29
DE69325450T2 (de) 1999-12-23
EP0636024B1 (en) 1999-06-23
JP4014114B2 (ja) 2007-11-28
AU3963993A (en) 1993-11-18
HK1007923A1 (en) 1999-04-30
EP0636024A1 (en) 1995-02-01
CA2118114C (en) 2003-06-17
ATE181502T1 (de) 1999-07-15
US5550145A (en) 1996-08-27

Similar Documents

Publication Publication Date Title
DK0636024T3 (da) Potensering af antimikrobielle virkninger
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
DE69533593D1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
RU94041836A (ru) Производные амидина, смесь их изомеров или отдельные изомеры и их соли, фармацевтическая композиция с антагонистической в отношении лейкотриена в*004 активностью
GEP20002068B (en) Antimicrobial Compositions Containing a C3-C6 Alcohol
KR102272901B1 (ko) 메조-2,3-부탄디올을 방부제로서 함유하는 피부 외용제 조성물
DE69508918T2 (de) Synergistische antimikrobielle zusammensetzung die methylen-bis-thiocyanat enthält
DE60035133D1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
UA41285C2 (uk) Креатин фосфат і його фармацевтично прийнятні солі для лікування пухлин та фармацевтична композиція, що має протипухлинну активність
Matousek et al. The effects of four acidifying sprays, vinegar, and water on canine cutaneous pH levels
JPS56113706A (en) Mildewcide composition for industrial use
MD1762B2 (ro) Derivaţi de pirazoliloxipiridină, procedeu de obţinere a lor, compoziţie erbicidă, procedeu de combatere a plantelor indezirabile
ES2132283T3 (es) Derivados n-heteroaril sustituidos de propanamida utiles en el tratamiento de enfermedades cardiovasculares.
JPH03157311A (ja) にきび用化粧料
FR2534809B1 (fr) Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci
GB2094623A (en) Compositions containing hydrogen peroxide
IL90528A0 (en) Propanolamine derivatives,their preparation and pharmaceutical compositions containing them
DE69941459D1 (de) Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
Jelenko et al. Topical lipid protection of burned subjects and their wounds
CA1102238A (en) Composition for treating burns
JPS6160676A (ja) Ｎ−シクロヘキシル−ｎ−メトキシ−２，５−ジメチルフラン−３−カルボキサミドの安定化方法
GEP20002241B (en) Polymorphs and Hydrated Forms of Lesopitron Dichlorohydrate, Methods for Its Preparation and Pharmaceutical Compositions Containing Same
ES2059594T3 (es) Peptidos con actividad inhibidora de sistemas enzimaticos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
SE9302006D0 (sv) Protein formulation